References
- Aroutcheva AA et al. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems. Clinical Infectious Disease. 2001;33 :1022-7. https://doi.org/10.1086/323030
- 김연희, 이흥식. Gardnerella vaginalis에 대한 한약재의 항균활성. 한국미생물.생명공학회지. 2006;34:70-3.
- 조성남. 질염. 대한산부인과학회 연수강좌. 2004;33:77-85.
- 임성민, 이동녕, 김형준. 질염에 대한가자, 차전자, 천궁, 포공영, 황금의 효과. 대한한방부인과학회지. 2004;17(4):34-45.
- 葛洪. 肘後備急方. 北京:人民衛生出版社. 1996:108.
- 김영훈. 청강의감. 서울:성보사. 2001:256, 379.
- 鞠潤範등. 方劑學. 서울:永林社. 2008:193-5.
- 윤상현, 나영설, 민병일. 龍膽瀉肝湯이 어성초에 의한 뇌졸중에 병발된 폐렴의 치험 3례. 경희의학. 1991;7(4):431-8.
- Lee TY, Chang HH. Longdan Xiegan Tang has immunomodulatory effects on CD4+CD25+ T cells and attenuates pathological signs in MRL/lpr mice. Int J Mol Med. 2010;25(5):677-85.
- 윤정숙, 문희원, 이미애. 다제내성 Pseudomonas aeruginosa 균주의 항균제 병합효과. 대한임상미생물학회지. 2006;9:1-6.
- Pfaller MA et al. Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob Agents Chemother. 1992; 36:1805-9. https://doi.org/10.1128/AAC.36.9.1805
- Tenover FC et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol. 1998;36:1020-7.
- Pfaller MA et al. Multicenter evaluation of four methods of yeast inoculum preparation. J Clin Microbiol. 1988; 26:1437-41.
- Janssen AM, Scheffer JJ, Baerheim SA. Antimicrobial activity of essential oils: a 1976-86 literature review. Aspects of the test methods. Planta Med. 1987;53:395-8. https://doi.org/10.1055/s-2006-962755
- Hauth JC et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med. 1995;333:1732-6. https://doi.org/10.1056/NEJM199512283332603
- Mayaud R. Tackling bacterial vaginosis in developing countries. Lancet. 1997; 350:530-1. https://doi.org/10.1016/S0140-6736(97)22034-9
- Hillier SL. Clindamycin treatment of bacterial vaginosis. Rev Contemp Pharmacother. 1992;3:263-8.
- Hay PE. Therapy of bacterial vaginosis. J Antimicrob Chemother. 1998;41:6-9. https://doi.org/10.1093/jac/41.1.6
- 대한한방부인과학 편찬위원회. 한방여성의학. 서울:정담. 2002:267-9.
- 한복진, 우상규, 신현경. 목통(Akebia quinata Decaisne)의 물추출물이 Clostridium perfringens 및 주요 장내미생물의 생육에 미치는 영향. 산업미생물학회지. 1995;23:633-40.
- 김정균 등. 천연한약재 (목통, 삼릉, 치자) 추출물의 항산화효과 및 항균활성효과. 농업생명과학연구. 2003;37 :69-75.
- 도정애. 택사의 항균 및 항진균 작용에 관한 연구. 생약학회지. 1996;27:378-82.
- 서권일 등. 택사 추출물의 항균 및 항산화 효과. 생명과학회지. 2000;10 :524-8.
- 유시용 등. 당귀와 백지로부터 분리한 Coumarin계 물질들의 식물병원균에 대한 항균활성. 한국농약과학회지. 2001;5:26-35.
- 윤경원, 최성규. 당귀속 2종 식물의 항균활성. 한국자원식물학회지. 2004;17 :278-82.
- Lee S et al. Antibacterial coumarins from Angelica gigas roots. Arch Pharm Res. 2003;26:449-52. https://doi.org/10.1007/BF02976860
- Yang D et al. Study on the inhibitory activity, invitro, of baicalein and baicalin against skin fungi and bacteria. ZhongYaoCai. 2000;23:272-4.
- Yang ZC et al. The synergistic activity of antibiotics combined with eight traditional Chinese medicines against two different strains of Staphylococcus aureus. Colloids Surf B Biointerfaces. 2005;41:79-81. https://doi.org/10.1016/j.colsurfb.2004.10.033
- Wu J, Hu D, Wang KX. Study of Scutellaria baicalensis and Baicalin against antimicrobial susceptibility of Helicobacter pylori strains in vitro. ZhongYaoCai. 2008;31:707-10.
- 최철순 등. 치자(梔子) 수용성 추출액의 결핵균 외의 기타 Mycobacteria에 대한 항균작용. 大韓微生物學會誌. 1986;21:53-62.
- Fukai T et al. Antimicrobial activity of licorice flavonoids against methicillinresistant Staphylococcusaureus. Fitoterapia. 2002;73:536-9. https://doi.org/10.1016/S0367-326X(02)00168-5
- He J et al. Antibacterial compounds from Glycyrrhiza uralensis. J Nat Prod. 2006;69:121-4. https://doi.org/10.1021/np058069d
- Yang C et al. Determination of glycyrrhizic acid in different decoctions of sanaotang by HPLC and comparison with antifugal effects in vitro. ZhongguoZhongYaoZaZhi. 2007;32:1031-4.
- Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin -resistant Staphylococcusaureus. N Engl J Med. 2007;357:380-90. https://doi.org/10.1056/NEJMcp070747
- Darley ES, MacGowan AP. Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother. 2004;53:928-35. https://doi.org/10.1093/jac/dkh191
- Russell. Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes. Ann Pharmacother. 2000;34:936-9. https://doi.org/10.1345/aph.19095
- Lamont RF. Can antibiotics prevent preterm birth--the pro and con debate. BJOG. 2005;112:67-73. https://doi.org/10.1111/j.1471-0528.2005.00589.x
- Homer MJ et al. Babesiosis. Clin Microbiol Rev. 2000;13:451-69. https://doi.org/10.1128/CMR.13.3.451-469.2000
- Pleyer U, Torun N, Liesenfeld O. Ocular toxoplasmosis. Ophthalmologe. 2007;104 :603-15. https://doi.org/10.1007/s00347-007-1535-8
- Fishman JA. Treatment of infection due to Pneumocystis carinii. Antimicrob Agents Chemother. 1998;42:1309-14.
- Rossi S. Australian Medicines Handbook Pty Ltd, Adelaide, 2006.
- Starr J. Clostridium difficile associated diarrhoea:diagnosis and treatment. BMJ. 2005;331:498-501. https://doi.org/10.1136/bmj.331.7515.498
- Pigrau C et al. Osteomyelitis of the jaw:resistance to clindamycin in patients with prior antibiotics exposure. Eur J Clin Microbiol Infect Dis. 2009;28:317-23. https://doi.org/10.1007/s10096-008-0626-z
- Muli F, Struthers JK. Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. Antimicrob Agents Chemother. 1998;42:1428-32.
- Altrichter T, Heizmann WR. Gardnerella vaginalis: transport, microscopy, testingresistance. Geburtshilfe Frauenheilkd. 1994;54:606-11. https://doi.org/10.1055/s-2007-1022350
- Zhang L et al. High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci USA. 2007;104:4606-11. https://doi.org/10.1073/pnas.0609370104
Cited by
- 완대탕(完帶湯)의 Gardnerella vaginalis에 대한 시험관내 항균력 및 Clindamycin과 병용효과 vol.25, pp.1, 2011, https://doi.org/10.15204/jkobgy.2012.25.1.034